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Abstract
Traditional read-across approaches typically rely on the chemical similarity principle to predict
chemical toxicity; however, the accuracy of such predictions is often inadequate due to the
underlying complex mechanisms of toxicity. Here we report on the development of a hazard
classification and visualization method that draws upon both chemical structural similarity and
comparisons of biological responses to chemicals measured in multiple short-term assays
(”biological” similarity). The Chemical-Biological Read-Across (CBRA) approach infers each
compound's toxicity from those of both chemical and biological analogs whose similarities are
determined by the Tanimoto coefficient. Classification accuracy of CBRA was compared to that
of classical RA and other methods using chemical descriptors alone, or in combination with
biological data. Different types of adverse effects (hepatotoxicity, hepatocarcinogenicity,
mutagenicity, and acute lethality) were classified using several biological data types (gene
expression profiling and cytotoxicity screening). CBRA-based hazard classification exhibited
consistently high external classification accuracy and applicability to diverse chemicals.
Transparency of the CBRA approach is aided by the use of radial plots that show the relative
contribution of analogous chemical and biological neighbors. Identification of both chemical and
biological features that give rise to the high accuracy of CBRA-based toxicity prediction facilitates
mechanistic interpretation of the models.
INTRODUCTION
The chemical similarity principle1, 2 posits that chemically similar compounds are likely to
exhibit similar effects. Consequently, a variety of chemical similarity-based methods have
been developed to predict chemical-induced responses from chemical structure alone. The
chemical similarity principle provides the basis for both straightforward read-across
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analysis,3-7 and more complex machine learning-based approaches used in Quantitative
Structure Activity-Relationship (QSAR) modeling.8-10
Chemical structure-based prediction methods face limitations, especially when the challenge
is to accurately predict complex in vivo outcomes.8, 11 Data from in vitro screening of
thousands of chemicals in hundreds of experimental systems provide additional biological
activity information at molecular and cellular levels potentially useful for predictive
toxicology modeling.12-14 Indeed, integration of chemical structural features and biological
screening data provides important advantages over traditional QSAR modeling, such as
improved prediction accuracy,15, 16 greater coverage of chemical space and a better
interpretation of chemical and biological features.17
While QSAR modeling approaches have grown in popularity and complexity, end-users
often show preference for simple and more transparent methods such as read-across
conducted, e.g., using the OECD QSAR Toolbox (http://www.qsartoolbox.org/). The read-
across methodology requires chemical (i.e., structure-based) similarity as a starting point.
The objective of this method is to predict the toxicity behavior of a compound (i.e., produce
an equivalent of a test result) by inferring from structurally similar chemicals with available
toxicity data. Grouping and read-across of chemicals in a hazard and/or risk assessment
context is well established and can be used to satisfy information requirements under
Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation
in the European Union. For example, more than 20% of high production volume chemicals
submitted for the first REACH deadline relied on read-across for hazard information on a
number of toxicity endpoints necessary for registration (http://echa.europa.eu/documents/
10162/13639/alternatives_test_animals_2011_en.pdf). Under REACH, flexibility exists for
how the analogues are selected; however, the read-across argument needs to be convincingly
substantiated with scientifically credible justification. Thus, even though chemical structure-
based read-across represents an alternative to standard animal-based tests, the inherited
uncertainty of the prediction, combined with a lack of a standardized framework for its
application by the decision-makers, creates a need to increase confidence in prediction and
utilize visual aids for presenting evidence in a transparent manner.
Although chemical and biological factors are sometimes considered using a weight-of-
evidence framework,4, 6, 7 these approaches are largely qualitative, not completely
transparent, and may be prone to bias. Hence, there is a need to automate a read-across
process that would combine both chemical and biological factors and yet, keep the process
transparent for expert interrogation. To that end, we introduce a quantitative toxicity
prediction approach combined with a visualization methodology, termed chemical-
biological read-across (CBRA), that relies not only on inherent chemical properties
(chemical descriptors), but also on biological profiles measured by short-term experimental
assays (biological descriptors). A graphical display of the compound's classification, along
with the identity of the neighbors and weights applied, is employed to increase transparency
and interpretability. Using several data sets with short-term bioassay profiles, we




Four data sets were used in this study (descriptor matrices and prediction endpoints of
compounds are available as part of the Supporting Information). The first data set contained
127 compounds from the Toxicogenomics Project-Genomics Assisted Toxicity Evaluation
system (TG-GATES18). The target property for prediction is sub-chronic hepatotoxicity
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previously modeled in Low et al17 based on liver histopathology and clinical chemistry
findings over 28 days of repeat dosing.18 Gene expression data (biological features) and
chemical descriptors (inherent chemical features) were processed as explained in Low et
al.17 Briefly, of the 31,042 probes on the arrays, we removed those that were consistently
not expressed or did not change their expression value across all compounds between treated
vs. vehicle control groups. Next, 2,991 transcripts were selected that varied in their
expression across all the compounds based on the following criteria: the largest change of
any transcript over its untreated equivalent was over 1.5 fold and the smallest false
discovery rate (Welch t-test) was less than 0.05. Then, transcripts with low variance (all, or
all but one value is constant) were excluded and further, one of each pair of transcripts with
high pairwise correlation (r2>0.9) chosen randomly, was removed; this left 2,923 transcript
variables which were range scaled and used for model building. Models were built using
supervised variable selection methods and five-fold external validation procedure each of
the five subgroups (20% of the dataset) was systematically treated as an external set while
the model was developed with the remaining four groups used as training set (80% of the
dataset). In the end, we selected 85 unique transcripts (5 sets of 30 top-ranked transcripts per
fold) to avoid selection bias introduced by a supervised selection process. Similar filtering
procedures were applied prior to model building to chemical descriptors, i.e., prior to model
building low variance (SD<10−6) and highly correlated descriptors (one of a pair of
descriptors with pair-wise r2>0.9) were removed).
The second data set contained 132 compounds (DrugMatrix®, https://ntp.niehs.nih.gov/
drugmatrix). The biological descriptors were the expression of 200 genes in the rat liver (5
day repeat dosing), that were selected as detailed in Natsoulis et al.20 The data for the
prediction target, hepatocarcinogenicity, was compiled in a related study by Fielden et al19
using literature sources and the Carcinogenicity Potency Database (CPDB, http://
www.epa.gov/ncct/dsstox/sdf_cpdbas.html).
The third and fourth data sets were from Lock et al21 in which 240 compounds were tested
for cytotoxicity (intracellular ATP and caspase-3/7 apoptosis) in 84 lymphoblastoid cell
lines with different genotypes. The 148 biological descriptors used here were the
consolidated cytotoxicity profiles derived as detailed in Sedykh et al.15 Of the original 240
compounds, 185 compounds were assigned mutagenicity labels according to CCRIS (http://
toxnet.nlm.nih.gov/cgi bin/sis/htmlgen?CCRIS) and 122 compounds were assigned rat oral
LD50 according to ChemIDplus (http://chem.sis.nlm.nih.gov/chemidplus/). Because CCRIS
provides detailed-level mutagenicity test results (including test strains, concentrations, and
type of metabolic activation), the final mutagenicity assignments were determined using the
protocol described in Mortelmans et al:22 mutagens must test positively in any one of the
five standard Ames Salmonella test strains; non-mutagens, in contrast, must be consistently
negative (in at least 4 out of 5 test strains). Additionally, when Ames Salmonella strains
beyond the standard five were available, we defined mutagens as those tested positively in at
least 20% of the strains and non-mutagens as those tested negatively in at least 80% of the
strains regardless of metabolic activation. For the other classification endpoint, continuous
rat oral LD50 values were split into two classes based on a threshold of 300 mg/kg,
consistent with the threshold separating categories 1-3 and 4-6 in Globally Harmonized
System of Classification and Labeling of Chemicals.23
Chemical descriptors and data processing
Chemicals utilized in all data sets underwent structural curation according to the procedures
described in Fourches et al.24 This involved standardizing the molecular structures and
removing salts, duplicates and problematic structures (e.g., metal-containing, molecular
weight > 2000). Next, Dragon (v.5.5, Talete SRL, Milan, Italy) descriptors were computed
for all chemicals.
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After additional treatment of gene expression data (data sets 1 and 2, see above), all
chemical and biological descriptors were range scaled to fall between 0 and 1. Furthermore,
descriptors with low-variance (standard deviation <10−6) or one of any pair of descriptors
with high intercorrelation (pairwise r2 >0.9) were removed.
Quantitative read-across methodology
For read-across, the predicted activity of a compound (Apred) was calculated using the
following equation (Equation 1) from the similarity (Si) weighted aggregate of the activities
Ai of k nearest neighbors.
[1]
The pairwise Tanimoto similarity, Si, between the molecule of interest (A) and its ith
neighbor (B), was calculated from the Jaccard distance dJac [Equation 2, (Willett et al.,
1998)] across descriptors x1,..., xp. For a set of range-scaled continuous descriptors,
Tanimoto similarity is normalized between 0 and 1 with 1 corresponding to identical pairs.
[2]
The similarity-weighted aggregate in Equation 1 ensures that the activities of more similar
neighbors are given higher weights when calculating the predicted activity.
For CBRA, compound activity was estimated from sets of neighbors in both the biological
(bio) and chemical (chem) data (Equation 3).
[3]
Two sets of nearest neighbors (kbio biological neighbors in the biological space
characterized by bioassay profiles and kchem neighbors in the chemical space characterized
by Dragon descriptors) were used for the estimation of the toxicity for each test compound.
Activities of nontoxic compounds were assigned “−1” while those of toxic compounds were
assigned “+1”. The predicted classification threshold was set at zero such that compounds
with negative predicted activity were considered as nontoxic and toxic otherwise.
Read-across was performed in two ways depending on how the maximum number of
neighbors was determined: 1) by a similarity threshold (RA-sim), or 2) by a set value of k
(RA-kNN). RA-sim included all neighbors with similarity greater than or equal to a
similarity threshold set at 0, 0.6, 0.7, 0.8, or 0.9; RA-kNN included only k nearest neighbors
(possible k values: integers from 1 to 5). Limiting the number of nearest neighbors by 5 is
arbitrary; generally it should be understood that the selection of a large number of nearest
neighbors would undermine the nearest neighbor selection principle so “5” is a threshold
number we have been using typically in our implementation of the kNN QSAR method.25
Other models using both biological and chemical descriptors
In addition to CBRA, other approaches combining biological and chemical data for toxicity
prediction were examined. First, biological and chemical descriptors were pooled together
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constituting a “hybrid” space which generated a single set of k nearest neighbors for each
molecule (see Equation 1 where k=khybrid). Second, compounds’ activities were predicted
by developing independent biological read-across and chemical read-across models and
pooling the resulting predictions, essentially forming an ensemble model (Equation 4).
[4]
Model evaluation
External 5-fold cross validation—All models were evaluated using an external 5-fold
cross validation. Briefly, each data set was randomly divided into five equal parts with the
same toxic/nontoxic ratio before modeling. Each of the five parts was left out in turn to form
an external set for validating the model developed on the remaining four parts (modeling
set). For each target compound in the external set, neighbors were selected from the
modeling set and not from the external set.
Internal 10-fold cross validation in read across kNN method—In RA-kNN,
optimal kbio and kchem were selected from values between 1 and 5 by additional internal 10-
fold cross-validation. Briefly, each modeling set was further divided according to a 10-fold
cross-validation scheme, forming ten pairs of training and test sets. For each training set, we
performed a grid search across all 25 possible pairs of kbio and kchem values and validated
the models using the corresponding test set. For each pair of kbio and kchem values, the
balanced accuracies across the ten test sets were averaged. The pair yielding the highest
mean balanced accuracy was considered to be optimal and its kbio and kchem values were
subsequently applied to the corresponding external validation set. Therefore, the five
modeling sets resulted in five optimal models with various kbio and kchem values.
Y-randomization—The y-randomization test (randomization of the response) was
performed to ensure that models were robust and not due to chance correlations. After
random permutation of the activity labels in the modeling sets, models were rebuilt
following the same workflow as described above. This protocol was repeated 30 times.
Performance of the models generated from the permuted labels was compared to that of the
models derived from the original data sets. Statistical significance of the difference in
classification accuracy was determined with one-tailed one-sample t-test.
Prediction performance metrics—All metrics characterizing model performance [i.e.,
specificity, sensitivity, accuracy, balanced accuracy, and area under curve (AUC)] were
obtained from external 5-fold cross-validation. Metric values close to 1 indicate high
classification accuracy while 0.5 serves as the random baseline for binary classification.
Specificity is the fraction of compounds predicted correctly within the nontoxic class;
conversely, sensitivity is the fraction of compounds predicted correctly within the toxic
class. Accuracy is the fraction of compounds predicted correctly in total. Balanced accuracy
is the average of the rates correctly predicted within each class ((specificity + sensitivity)/2).
AUC is the area under the receiver operating characteristic curve of sensitivity against (1-
specificity). Thus, AUC is a function of sensitivity and specificity, providing an overall
accuracy metric independent of a predefined activity threshold unlike the other prediction
metrics which were calculated using a predefined activity threshold of zero (for activity
values ranging between −1 to +1).
Coverage of the models is reported as the fraction of compounds in the external set that are
within the applicability domain (AD) for which reliable predictions are expected to be
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obtained. In RA-sim, a target compound is within the AD if there exists at least one
neighbor in the modeling set whose similarity is above the similarity threshold; in RA-kNN,
a compound is within the AD if there exists at least one neighbor with a minimum similarity
of 0.3. Standard errors were calculated by the bootstrap method26 using 1000 sampling
trials.
Model interpretation
Identification of informative descriptors—Adapted from the local importance score
used in the random forest method,27 we use a local importance score based on x-
randomization to rank descriptors by their contribution to a target compound's predicted
activity. X-randomization involves the random permutation of a descriptor x across the
modeling set such that the descriptor's effect on the model before and after permutation is
compared. This difference is expected to be more pronounced for important descriptors.
Specifically, after permutation, the similarity between the target compound and its k
neighbors (previously used for RA-kNN) will change. This resultant change in similarity is
averaged over 99 random permutations to obtain the local importance score I(x,compound)
which measures the descriptor x's contribution towards the target compound's predicted
activity. This procedure was repeated for each descriptor per target compound. A high local
importance score indicates that the descriptor is highly contributory to the target compound's
prediction.
Visualization of nearest neighbors using radial plots—To visualize the information
used to generate the predicted activity of a compound (Apred), the radial plot is used (see
Figures 1-3 for examples). The central node marks the target compound. Surrounding it are
nodes representing biological neighbors (left hand side) and chemical neighbors (right hand
side), all colored according to their known toxicity assignments (red=toxic, black=nontoxic).
The relative position of each neighbor from the central node (i.e., edge length) reflects the
Jaccard distance (Equation 2) from the target compound. The nearest neighbors (shortest
edges) are placed closest to the 12 o'clock position. Each radial plot displays all the
neighbors relevant to a compound's prediction (i.e., kchem chemical neighbors and kbio
biological neighbors above 0.3 Tanimoto similarity, consistent with the AD similarity
threshold for RA-kNN). The algorithm for generating the radial plots was written in R
Statistical Software (version 2.14; R Foundation for Statistical Computing, Vienna, Austria)
and is available as part of the Supporting Information.
RESULTS
Visualisation of the chemical-biological read across classification
The premise of this study was to establish a transparent methodology for inferring a
compound's potential toxicity from its biological and chemical analogs. Here, we use
graphical means to illustrate how CBRA integrates information from both biological and
chemical analogs of a compound to predict its toxicity. Because the relevant information
(the analogs, their similarities and known toxicity assignments) can be communicated using
the radial plot, CBRA offers a highly transparent and interpretive method for hazard
classification.
Figures 1-3 show the radial plots of three case study compounds, classifying them as
hepatotoxic or not (see Methods for description of hepatotoxicity class designation) using
both their biological (similar toxicogenomic profiles) and chemical (similar structures)
analogs in the TG-GATES data set. Figure 1 depicts the basis for classifying
chloramphenicol as “toxic”. The central node was colored red to denote chloramphenicol's
known toxicity. On the left hand side, all five biological neighbors were labeled as toxic
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(red) and they are highly similar to chloramphenicol (similarities: 0.826-0.857). On the right
hand side, the five closest chemical neighbors are nontoxic (black, similarities:
0.645-0.667). All neighbors’ activities are aggregated according to their similarity weights
by CBRA (Equation 3), yielding Apred=+0.126, i.e., a “toxic” prediction concordant with the
known “toxic” assignment. Figure 2 shows the opposite case in which the correct
classification of carbamazepine (known to be nontoxic; Apred=−0.099) was due to its greater
similarity with its chemical neighbors (similarities: 0.721-0.813). Figure 3 shows that
benzbromarone's biological and chemical neighbors were mostly toxic (red), yielding
concordant predictions (Apred=+0.688), in agreement with its known toxicity.
Figure 4 provides a visual comparison of radial plots for selected compounds from the TG-
GATES data set that may facilitate expert judgment of each predicted classification. As with
previous radial plots, each central node represents the compound of interest and is colored
according to its experiment-derived toxicity (black=nontoxic, red=toxic). Radial plots were
organized by the predicted activities using only chemical neighbors (horizontal axis) and
those using only biological neighbors (vertical axis). As such, the compounds can be
assessed by whether the chemical or biological neighbors had higher contribution to the final
classification. The lower left corner (e.g., quinidine) is populated by radial plots with mostly
nontoxic (black) neighbors while the upper right corner (e.g., benzbromarone) is filled by
those with mostly toxic (red) neighbors. Conversely, other radial plots involve discordant
predictions. Such radial plots are surrounded by neighbors of various toxicities (i.e., edges of
various colors). Despite the discordance, the target compounds were still correctly predicted
by CBRA because the activities of more similar neighbors (shorter edges) were given higher
weight than those of less similar neighbors (longer edges). This simple visualization
identifying neighbors based on an objective and standardized similarity metric such as the
Tanimoto similarity allows users to assess the relevance of the neighbors and their
contribution to the final prediction for every compound of interest.
Model performance
RA-kNN vs RA-sim—As read-across can be performed in two ways using either a
similarity threshold (RA-sim) or a set value of k (RA-kNN), we first compared these two
approaches on the TG-GATES data set (Figure 5 and Supporting Information Table 1). The
first approach (RA-sim, solid filled bars in Figure 5) utilizing chemical descriptors only
(“chemical read-across”, white solid bars), showed that higher balanced accuracy may be
achieved by restricting chemical similarity thresholds; however, the cost of such improved
accuracy is much reduced coverage. RA-sim using gene expression data only (“biological
read-across”, black solid bars) had a higher balanced accuracy as compared to chemical
read-across when all compounds were considered (i.e., 100% coverage). However, the
accuracy of biological read-across did not increase markedly when more stringent similarity
thresholds were applied. Finally, CBRA (dark gray solid fill) showed the highest balanced
accuracy while being the least affected by the increasing similarity threshold. RA-sim
utilizing hybrid descriptors resulting from pooling both chemical and biological descriptors
(light gray solid bars) together, exhibited intermediate accuracy. The second read-across
approach (RA-kNN, patterned fill) showed comparable or higher balanced accuracy across
all four types of methods integrating chemical and biological descriptors when compared to
RA-sim (solid fill). For this reason, RA-kNN was selected as the preferred algorithm for
read-across.
Comparison of read-across in biological and/or chemical spaces—Next, we
tested the performance of various read-across methods for different toxicity endpoints (liver
toxicity and carcinogenicity, mutagenicity and acute lethality) and for different “biological
descriptor” types (e.g. gene expression data from two different studies and in vitro
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cytotoxicity screening data). For this, we used both chemical and/or biological descriptors
and the RA-kNN algorithm. In all four data sets, we applied: 1) chemical read-across (white
bars); 2) biological read-across (black bars); 3) hybrid read-across by pooling chemical and
biological descriptors (Equation 1, light gray bars); 4) ensemble read-across from pooling
predictions from (1) and (2) (Equation 4, dark gray bars); and 5) CBRA (Equation 3,
medium gray bars). Figure 6 and Supporting Information Tables 1 and 2 show a comparison
of the performance of the various read-across methods in each data set.
While chemical read-across (white bars) exhibited highest balanced accuracy of
classification for some endpoints (i.e., mutagenicity and rat acute toxicity), biological read-
across (black bars) had greater balanced accuracy for data sets 1 and 2 of rat hepatotoxicity
and carcinogenicity, respectively, where biological descriptors represented gene expression
data. However, biological read-across based on in vitro cytotoxicity screening data alone in
data sets 3 and 4 exhibited the poorest classification accuracy (close to 50%), a result similar
to that reported previously16. Importantly, the balanced accuracy of CBRA (medium gray
bars) was consistently among the highest across all types of read-across models. Still, in
three data sets (rat hepatotoxicity, mutagenicity, and rat acute toxicity), CBRA's
performance, though among the best, did not surpass that of the simpler chemical read-
across (white bars) or biological read-across (black bars). Similar outcomes were obtained
when a comparison was made of the number of compounds correctly predicted by chemical
read-across, biological read-across, and CBRA (Figure 7). Thus, we posit that given CBRA's
consistently good performance, it should be employed where possible because it often offers
the best chance of improving classification accuracy and model interpretation.
Y-randomization test—The prediction performance of all models presented in this study
is given in Supporting Information Table 1. Most models built with real data significantly
outperformed those generated by y-randomization (p-value < 0.05) and hence, were unlikely
to be fitted by chance. There were two exceptions, however, i.e., models whose balanced
accuracies were very poor (50%, 52%), i.e., indistinguishable from the random baseline of
50% (Supporting Information Table 1).
DISCUSSION
Improvements due to ensemble modeling and enhanced aggregation
Ensemble models have been shown to be more accurate than their constituent models.28 The
CBRA approach, effectively an ensemble model, utilizes two distinct descriptor types, i.e.,
chemical and biological, to increase classification accuracy and uncover associations
between different types of descriptors that may characterize each compound. Enhanced
aggregation employed by CBRA ensures that the more similar neighbors have higher
weights, regardless of whether they are biological or chemical neighbors.
Our results show that simple ensemble modeling, which gives equal weights to both
chemical and biological models, is insufficient to achieve high classification accuracy, as
illustrated by the modest results of the simple ensemble model (dark gray, Figure 6). Instead,
enhanced aggregation employed by CBRA ensures that the more similar neighbors have
higher weights, regardless of whether they are biological or chemical neighbors. This feature
of CBRA is perhaps best exemplified by the following three case studies and their radial
plots (Figures 1-3) illustrating how highly similar neighbors drive the prediction outcome.
These case studies were selected to represent: 1) prediction driven by biological neighbors,
2) prediction driven by chemical neighbors, and 3) concordant predictions by biological and
chemical neighbors.
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Case study: Chloramphenicol (biological space-based prediction)
Chloramphenicol (Figure 1 and Supporting Information Table 3) is an anti-bacterial drug
whose hepatotoxicity was linked to oxidative stress initiated by reactive metabolites29.
Chloramphenicol increased the level of serum enzymes, as well as caused liver hypertrophy
and necrosis in treated rats in the TG-GATES studies.18 There is greater similarity in
toxicogenomics profiles between chloramphenicol and its several “toxic” biological
neighbors (0.83-0.86) than that with its nontoxic chemical neighbors identified using
inherent chemical properties (0.65-0.67).
The gene expression profiles of chloramphenicol and its highly similar biological neighbors
across 30 genes showed a consistent gene signature (Supporting Information Figure 1A). In
contrast, chloramphenicol and its chemical neighbors were characterized by relatively
dissimilar descriptor profiles (Supporting Information Figure 1B). Several genes critical to
the prediction of chloramphenicol's activity (Abce1, Tomm22 and Bmf) are known to be
implicated in mitochondrial and cell cycle regulation processes (Supporting Information
Table 4). Such deregulation is consistent with the known oxidative stress mediated
hepatotoxicity of chloramphenicol. More importantly, this analysis indicates that statistically
significant features elucidated by the CBRA model agree with the existing mechanistic
knowledge of the compound toxicity. Thus, such model interpretation by CBRA may
generate hypotheses about a compound's possible mechanism when only short-term assays
are available.
Case study: Carbamazepine (chemical space-based prediction)
Carbamazepine is an anti-convulsant drug that acts on neuronal voltage-gated sodium
channels. In the TG-GATES data set, it was classified as non-hepatotoxic in the rat. The
case of carbamazepine (Figure 2) contrasts with that of chloramphenicol. Whereas
biological RA afforded more accurate prediction than chemical RA for chloramphenicol, the
opposite was found to be true for carbamazepine. Nonetheless, CBRA, in taking a
similarity-weighted aggregate of the activities of kbio=5 biological neighbors and kchem=5
chemical neighbors, correctly predicted carbamazepine as nontoxic.
Carbamazepine and its highly similar chemical neighbors, in addition to sharing several
chemical features, also exert similar pharmacological effects. Carbamazepine's nearest
chemical neighbors (phenytoin, pemoline, phenylbutazone and phenobarbital) are also anti-
convulsant drugs that share a tricyclic scaffold with a polar amide group in the middle
(Figure 2). This common chemical motif is also responsible for their anti-convulsant effects.
The associated pharmacophore involves an amide moiety in the middle and a side lipophilic
aryl ring for interaction with the sodium channel in order to exert the drug's anti-convulsant
effects.30, 31
Carbamazepine's nearest biological neighbors (bendazac, flutamide, chloramphenicol,
disulfiram and phenylanthranilic acid) have few obvious commonalities. Their gene
expression profiles across the 30 predictor genes showed considerable heterogeneity
(Supporting Information Figure 1C). They also induce liver injury via different mechanisms
and exhibit different histopathology and blood chemistry in the TG-GATES database. In this
instance, biological similarity determined by 24-hour gene expression may not suffice to
signal 28-day liver injury.
Case study: Benzbromarone (concordant chemical and biological predictions)
Benzbromarone is an anti-gout agent withdrawn from the market in 2003 due to
hepatotoxicity concerns.32 In the TG-GATES data set, both its biological and chemical
neighbors were predictive of its hepatotoxicity. Here, we show how CBRA can provide a
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prediction outcome bolstered by concordant predictions as well as postulate associations
between the biological and chemical neighbors for subsequent analysis (Figure 3).
Benzbromarone-induced hepatotoxicity is attributed to disruptions in the mitochondrial β-
oxidation of fatty acids, possibly mediated by peroxisome proliferator-activated receptor-
alpha (PPARα) activation.33 It exhibits a gene expression profile similar to those of its
biological neighbors (fenofibrate, benziodarone, clofibrate and WY-14643), all known
PPARα activators. Furthermore, the genes important for predicting benzbromarone's activity
(Bcs1l, Tomm20, Abce1 and LOC100360017, Supporting Information Table 4), relate to
mitochondrial functions, indicative of the mitochondrial-mediated hepatotoxicity observed
in benzbromarone.
In this case, benzbromarone's biological and chemical neighborhoods overlap and provide
concordant predictions, possibly indicative of common biological-chemical associations
between the two neighborhoods. The overlapping neighbor, benziodarone, exhibits PPAR
activity similar to its biological neighbors and a lipophilic, planar structure similar to its
chemical neighbors. In addition, the cross-talk between estrogen and other sex hormones
and PPAR-mediated signaling is well recognized,34 which makes the association of its
chemical analog, ethinyl estradiol, plausible. Hence, such cross-inference from one
neighborhood to another can still provide useful clues for formulating hypotheses about
biological-chemical associations, the strength of which are dependent on the extent of the
overlapping neighborhoods. Furthermore, such analysis provides a novel way for the
concurrent study of chemical and biological features and their underlying interactions.
Advantages and Limitations of CBRA
Read-across method is based on the expectation that chemically similar molecules should
elicit similar biological responses. It is worth noting, however, that whichever way the
chemical similarity is defined, it always has relative meaning; that is, the similarity search
exercise identifies the most similar compounds in a given set of compounds, and not
necessarily the most similar chemically feasible structures. Further, structure-activity
relationship landscapes are known to be “rough,” with many molecules appearing
chemically similar but nevertheless having rather different biological activities. The latter
observation is best illustrated by the frequent presence of so called “activity cliffs”35 in
many chemical data sets. It is for this reason that we observed different chemical and
biological neighbors for many compounds across four data sets that were evaluated. Thus,
we argue that it is critical to weigh in both chemical and biological neighbor's contribution
in predicting every compound's activity. Such “enhanced” aggregation underlying CBRA
exploits the complementary information inherent in both the chemical and biological
neighbors to arrive at the most optimal prediction.
It is due to the relative power of similarity that CBRA may yield incorrect predictions by
either or both set(s) of neighbors. In the latter case, neither biological nor chemical
neighbors are instructive for model prediction or interpretation. In the former case, using
either biological or chemical neighbors (instead of both as in CBRA) would yield better
predictions for certain compounds. However, such accuracy provided by one set of
neighbors may be limited to certain compounds and not the entire data set, as evident by the
slightly smaller fraction of compounds correctly predicted by biological or chemical read-
across models (50-77% overall accuracy, mean=65%, SD=9%) vs. that by CBRA (57-80%
overall accuracy, mean=69%, SD=10%, Supporting Information Table 1). In other words,
CBRA's predictions may be less accurate than either biological or chemical read-across for a
minority of compounds but the CBRA approach succeeds overall showing higher accuracy
on average as compared to other read-across methods.
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As with most ensemble models, the decreased interpretability and increased computational
cost may outweigh the gains in accuracy.36, 37 CBRA, like other instance-based learners, is
better suited to data sets where variable selection has already been performed to reduce
noise due to irrelevant variables.38 This variable selection step is necessary because, unlike
models employing variable-specific weights, all variables in CBRA, including irrelevant
ones, are given equal consideration when calculating similarity.
Despite certain limitations we argue that CBRA remains transparent and interpretable since
neighbors of each compound can be easily identified and important variables (chemical
features or specific genes) can be elicited as illustrated in our case studies. The important
variables not only suggest mechanisms of action for closer toxicological examination but
may also act as markers for a particular mechanism. Such marker profiles may help to
uncover the toxicity mechanisms of new compounds whose toxicities were previously
unknown. Additional studies may be undertaken to investigate if there are relationships
between classes of chemicals and the selection of significant genes as defined by the CBRA
method common to compounds in each chemical class.
In addition, the consideration of toxicokinetics may be essential for constructing a read-
across argument, but CBRA does not yet take this into account in the present format. The
similarity of toxicokinetic profiles, especially metabolism, is often considered before
weighing the similarity in the mechanism of action. It is therefore reasonable to conclude
that the inclusion of toxicokinetic descriptors may ultimately help in improving prediction
accuracy and acceptance of read-across. This is especially relevant when in vitro data is used
to predict in vivo endpoints.39 Indeed, CBRA may be extended to more than two spaces to
accommodate toxicokinetic considerations although additional visualization techniques40
may be required.
Recommendations for chemical-biological modeling and its application in hazard
assessment
Our experience and observations with using both chemical and biological descriptors
suggest the following methodological implications for predicting chemical hazards. First,
biological assays such as gene expression are expected to be more predictive than more
simple assays measuring binary biological responses in vitro (e.g., binding/nonbinding to a
target protein). Second, it is advantageous to consider biological variables relevant to the
prediction target. The bioassays may be selected rationally according to biological
pathways.41 Third, variable selection and rigorous model validation prevents selection bias
towards overly optimistic models.39 Thus, careful modeling and validation according to
OECD (Q)SAR principles8 is necessary to ensure robust and accurate models.42 Lastly,
irrelevant variables may affect some classification methods more than others. For example,
as explained earlier, instance-based methods including CBRA are more susceptible to
irrelevant variables while others such as random forest can better tolerate noisy variables.27
In addition, our work has potential practical applications for the use of read-across under
REACH and other regulatory initiatives. Read-across approach guidance under REACH
(http://www.reachonline.eu/REACH/EN/REACH_EN/articleXI.html) stipulates that “the
group concept requires that physicochemical properties, human health effects and
environmental effects or environmental fate may be predicted from data for reference
substance(s) within the group by interpolation to other substances in the group.” In this
sense, even though typical interpretation of “similarity” is focused on a common functional
group, or common precursors/breakdown products, the biological data provides additional
confidence for the consistent pattern in the “potency” of the compounds to elicit toxicity
across the category. CBRA's transparency in displaying the compounds selected for read-
across allows users to examine the suitability of the neighbors before relying on them for
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subsequent prediction. As such, CBRA satisfies the requirement for “adequate and reliable
documentation of the applied method” by providing a defined process for analog selection
and prediction, as well as enabling visual interpretation of the similarities across several data
domains.
Conclusions
Given the complex biological processes mediating chemical toxicity, hazard prediction will
benefit from the inclusion of biological data in addition to chemical information. Previously,
we have demonstrated that hybrid models of hepatotoxicity pooling biological (gene
expression profiles) and chemical features could not achieve higher accuracy than biological
models.17 Herein, we have developed CBRA as an alternative method combining the same
biological and chemical descriptors and demonstrated that its balanced accuracy was among
the best when compared with other models using biological and/or chemical descriptors.
This result was also replicated in three other data sets.
One reason for the success of CBRA is that, as a local modeling technique incorporating
relative similarity weighting scheme, it relies on objective metrics to predict toxicity class of
a compound when predictions made with chemical vs. biological neighbors disagree.
Additionally, since prediction is based on a small number of similar compounds, both the
modeling process and its outcome are transparent. All neighbors are displayed using star
plots that also show relative similarities between such neighbors and the target molecule
such that users can examine the arguments made by the model when assigning a specific call
(toxic or non-toxic) to the target compound. CBRA also highlights key biological and
chemical features for further mechanistic interpretation. In summary, CBRA represents a
novel hybrid read-across method that is both predictive and interpretable. It combines the
simplicity and transparency of read-across methods with the benefits afforded by more
sophisticated techniques such as ensemble modeling and instance-based learning while
incorporating modern diverse data streams, making CBRA a potentially appealing tool for
chemical hazard assessment.
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QSAR quantitative structure activity relationship
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A radial plot for chloramphenicol in the TG-GATES data set. The central node representing
the target compound chloramphenicol is surrounded by biological neighbors (left hand side)
and chemical neighbors (right hand side). Nearest (i.e., most similar) neighbors are placed at
the top. Neighbors are positioned from the target compound at a distance proportional to the
Jaccard distance. Edges and nodes are colored according to the known activity classification
(black: nontoxic; red: toxic).
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A radial plot for carbamazepine in the TG-GATES data set. See legend to Figure 1 for
details.
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A radial plot for benzbromarone in the TG-GATES data set. See legend to Figure 1 for
details.
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Radial plots of compounds in TG-GATES data set ordered by predictions based on chemical
neighbors (horizontal axis) and biological neighbors (vertical axis). Along the horizontal
axis, nontoxic predictions (black) by chemical neighbors are shown on the left and toxic
predictions (red) are shown on the right. Along the vertical axis, nontoxic predictions (black)
by biological neighbors are shown at the bottom while toxic predictions (red) predominate at
the top. Compounds predicted with high confidence by near neighbors of similar toxicities
are indicated by radial plots with short edges of the same color.
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Performance of RA-sim (solid fill) and RA-kNN (patterned fill) models for the TG-GATES
data set. RA-sim models were varied using various similarity thresholds for neighbor
selection. Models based on various spaces are denoted by colors: chemical space (white),
biological space (black), hybrid space (light gray), and chemical-biological spaces (dark
gray).
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Performance of various RA-kNN models for four data sets. The models are colored as
follows: chemical RA (white), biological RA (black), hybrid RA (from pooling chemical
and biological descriptors, light gray), ensemble RA (consensus of chemical RA and
biological RA, dark gray) and CBRA (gray). *Coverage values <0.95% are indicated on the
chart.
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Venn diagrams depicting the number of compounds correctly predicted by chemical RA
(blue circles), biological RA (red circles) and CBRA (yellow circles). Analysis was
conducted on four data sets as detailed in Methods. Four datasets were analyzed as detailed
in Materials and Methods: rat hepatotoxicity (A), rat hepatocarcinogenicity (B),
mutagenicity (C), and rat acute oral toxicity (D).
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